Backed by
Hong Kong Science and Technology Park
In Malaysia alone, an estimated 70% of couples cannot afford IVF. Around 40,000 cycles are needed each year — only 12,500 are performed, leaving a significant annual gap in treatment access.
A single IVF cycle in Southeast Asia can cost USD 11,000 or more — often a full year's salary. Multiple cycles are often required, making treatment financially unviable for most families.
Conventional IVF requires a full embryology laboratory, specialist staff, and expensive equipment. This restricts high-quality fertility care to a small number of large urban centres.
Across Southeast Asia, governments and health systems are increasingly concerned about declining birth rates. Fertility treatment is no longer just a personal matter — it has become a public health priority.
Fertility treatment is often treated as elective, not essential. In practice, this means access is largely restricted to higher‑income couples who can pay for multiple rounds of treatment.
Eve Fertility focuses on the majority who are currently left out: couples who would consider treatment if it were available closer to home, delivered in a familiar setting, and priced within reach.
EVEA intravaginal culture dramatically reduces the cost and complexity of treatment — without compromising outcomes.
Discover the solution →